New York is currently home to 4476 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
DB RCT for Specialized Phototherapy in Parkinson's Disease.
Recruiting
This is a pivotal study to determine whether light therapy can improve non-motor and motor function in Parkinson's disease, on top of current best medical treatment.
Gender:
ALL
Ages:
45 years and above
Trial Updated:
04/19/2024
Locations: University of Rochester, Rochester, New York
Conditions: Parkinson Disease
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
Recruiting
This research is aimed to address one of the big gaps in the current vision rehabilitation protocols for people with profound visual impairment by evaluating a multisensory approach. There are a growing number of clinical trials that recruit people with end-stage eye diseases and the rehabilitation plan following various treatments is not clear. It is important to address this in order to maximize the efficacy of such treatments and to improve the quality of life in people with profound visual i... Read More
Gender:
ALL
Ages:
Between 12 years and 99 years
Trial Updated:
04/18/2024
Locations: SUNY College of Optometry, New York, New York
Conditions: Low Vision Blindness, Visual Impairment, Quality of Life, Functional Visual Loss
The Effects of a Home-Based Fall Prevention Program on Community-Dwelling Elderly's Fall Risk Category
Recruiting
The primary goal of this dissertation study is to determine if a home-based multiplanar balance training program with electronic assistance, will be effective in reducing one's fall risk category. Hypothesis: After 12 weeks, there will be a statistically significant decrease in the fall risk category for individuals in a home-based multiplanar balance training and educational program with electronic assistance as compared to no change in the fall risk category for individuals in an educational... Read More
Gender:
ALL
Ages:
65 years and above
Trial Updated:
04/17/2024
Locations: Metro PT, New York, New York
Conditions: Fall Risk
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
Recruiting
The goals of this trial are: 1) To evaluate the safety and tolerability of C3 administration with Gemcitabine; and 2) To assess the disease response following C3 administration with Gemcitabine. The main question it aims to answer are: 1) Is C3 in combination with Gemcitabine safe, tolerable, and effective for reducing improving advanced stage pancreatic cancer? and 2) Can C3 in combination with Gemcitabine prolong the lives of patients with advanced stage pancreatic cancer. Participants will re... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/17/2024
Locations: SUNY Downstate Health Sciences University, Brooklyn, New York
Conditions: Pancreatic Cancer Metastatic
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Recruiting
The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/17/2024
Locations: Montefiore Medical Center, Bronx, New York
Conditions: Neurotrophic Keratopathy
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Northwell Health - North Shore University Hospital, Lake Success, New York
Conditions: Infusion Reactions
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma
Recruiting
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma is newly diagnosed, and to evaluate safety and tolerability of this combination at that dose.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Columbia University Medical Center - Herbert Irving Pavilion, New York, New York
Conditions: Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, GBM
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
Recruiting
This open-label extension study will evaluate the long-term effects of GB002 (seralutinib) in subjects who previously participated in a GB002 PAH study.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
04/16/2024
Locations: NYU Langone Health, New York, New York
Conditions: Pulmonary Arterial Hypertension
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
Recruiting
Neurotrophic keratitis (NK) is a condition where the cornea, or clear outer covering of the eye, has reduced sensation due to a variety of reasons. In more advanced cases of NK, the cornea can develop an area of thinning called an ulcer. The purpose of this research is to find out if Oxervate (cenegermin-bkbj 0.002%) an FDA-approved treatment for neurotrophic corneal ulcers leads to an increase in thickness of the corneal stroma (middle layer of the cornea) during and after treatment of a neurot... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: SightMD, Manhasset, New York
Conditions: Neurotrophic Ulcer, Neurotrophic Keratitis, Neurotrophic Corneal Ulcer, Neurotrophic Keratoconjunctivitis
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Recruiting
The goal of this clinical trial is to test how specific components of diet affect brain function and behavior for individuals with bipolar. The main question it aims to answer is how glucose and ketones each affect the brain's response to risk and reward. Participants will be asked to provide blood (to assess baseline measures of how the body uses energy), and then to receive two MRI scan sessions, on separate days. During each MRI scan session, participants will play three games, from which the... Read More
Gender:
ALL
Ages:
Between 18 years and 45 years
Trial Updated:
04/15/2024
Locations: Laufer Center for Physical and Quantitative Biology , Stony Brook University, Stony Brook, New York
Conditions: Bipolar Disorder, Bipolar Disorder Type 1
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
Recruiting
This research study is studying how thoughts, feelings, surroundings, and individual biology may contribute to why and how people experience anxiety or depression. We are trying to find out the wide variety of reasons that people may experience anxiety or depression, and why different people are helped by different forms of treatment. We are trying to determine why people stay in treatment, and what factors contribute to a positive or negative response to treatment. These reasons may be due to... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/15/2024
Locations: Singula Institute, 353 Lexington Avenue (Room 600), New York, New York
Conditions: Depression, Anxiety Disorders, Stress Related Disorder
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Recruiting
The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is designed to improve how paramedics treat seizures in children on ambulances. Seizures are one of the most common reasons why people call an ambulance for a child, and paramedics typically administer midazolam to stop the seizure. One-third of children with active seizures on ambulances arrive at emergency departments still seizing. Prior research suggests that seizures on ambulances continue due to und... Read More
Gender:
ALL
Ages:
Between 6 months and 13 years
Trial Updated:
04/15/2024
Locations: University at Buffalo, Buffalo, New York
Conditions: Seizures